New trade deal knocks out long-sought biologics protections for drugmakers
House Democrats negotiating with the Trump Administration on a new North American trade deal settled early on four issues: enforcement, labor and environmental standards and drug pricing.
On drug pricing, Politico reports, Trump crumbled within weeks of heightened negotiations.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 70,500+ biopharma pros reading Endpoints daily — and it's free.